연구용
제품 번호S2638
| 관련 타겟 | HDAC PARP ATM/ATR WRN DNA/RNA Synthesis Topoisomerase PPAR Sirtuin Casein Kinase eIF |
|---|---|
| 기타 DNA-PK 억제제 | Nedisertib (M3814) AZD7648 VX-984 CC-115 YU238259 LTURM34 Compound 401 |
| 세포주 | 분석 유형 | 농도 | 배양 시간 | 제형 | 활성 설명 | PMID |
|---|---|---|---|---|---|---|
| NCI-H1770 | Growth Inhibition Assay | IC50=0.02143 μM | SANGER | |||
| A172 | Growth Inhibition Assay | IC50=0.15316 μM | SANGER | |||
| NCI-H526 | Growth Inhibition Assay | IC50=0.28407 μM | SANGER | |||
| HDLM-2 | Growth Inhibition Assay | IC50=0.32345 μM | SANGER | |||
| HuO-3N1 | Growth Inhibition Assay | IC50=0.46636 μM | SANGER | |||
| NCI-SNU-1 | Growth Inhibition Assay | IC50=0.60994 μM | SANGER | |||
| SK-N-AS | Growth Inhibition Assay | IC50=0.62216 μM | SANGER | |||
| LoVo | Growth Inhibition Assay | IC50=0.86749 μM | SANGER | |||
| LAMA-84 | Growth Inhibition Assay | IC50=0.98833 μM | SANGER | |||
| CTB-1 | Growth Inhibition Assay | IC50=1.11546 μM | SANGER | |||
| KP-N-YS | Growth Inhibition Assay | IC50=1.14231 μM | SANGER | |||
| HH | Growth Inhibition Assay | IC50=1.18093 μM | SANGER | |||
| CHL-1 | Growth Inhibition Assay | IC50=1.21368 μM | SANGER | |||
| NB7 | Growth Inhibition Assay | IC50=1.24745 μM | SANGER | |||
| HL-60 | Growth Inhibition Assay | IC50=1.3819 μM | SANGER | |||
| 639-V | Growth Inhibition Assay | IC50=1.44128 μM | SANGER | |||
| NCI-H1793 | Growth Inhibition Assay | IC50=1.4584 μM | SANGER | |||
| NEC8 | Growth Inhibition Assay | IC50=1.5535 μM | SANGER | |||
| PA-1 | Growth Inhibition Assay | IC50=1.58294 μM | SANGER | |||
| D-423MG | Growth Inhibition Assay | IC50=1.69361 μM | SANGER | |||
| NCI-H292 | Growth Inhibition Assay | IC50=1.74013 μM | SANGER | |||
| SK-MEL-1 | Growth Inhibition Assay | IC50=1.79479 μM | SANGER | |||
| LB2241-RCC | Growth Inhibition Assay | IC50=2.14146 μM | SANGER | |||
| SK-MEL-3 | Growth Inhibition Assay | IC50=2.1649 μM | SANGER | |||
| MHH-PREB-1 | Growth Inhibition Assay | IC50=2.16609 μM | SANGER | |||
| BFTC-905 | Growth Inhibition Assay | IC50=2.16687 μM | SANGER | |||
| Ramos-2G6-4C10 | Growth Inhibition Assay | IC50=2.19909 μM | SANGER | |||
| G-361 | Growth Inhibition Assay | IC50=2.2168 μM | SANGER | |||
| MOLT-4 | Growth Inhibition Assay | IC50=2.21888 μM | SANGER | |||
| DEL | Growth Inhibition Assay | IC50=2.35564 μM | SANGER | |||
| MV-4-11 | Growth Inhibition Assay | IC50=2.3739 μM | SANGER | |||
| SK-NEP-1 | Growth Inhibition Assay | IC50=2.38783 μM | SANGER | |||
| RS4-11 | Growth Inhibition Assay | IC50=2.56023 μM | SANGER | |||
| HuH-7 | Growth Inhibition Assay | IC50=2.56702 μM | SANGER | |||
| A101D | Growth Inhibition Assay | IC50=2.61338 μM | SANGER | |||
| KG-1 | Growth Inhibition Assay | IC50=2.67924 μM | SANGER | |||
| KALS-1 | Growth Inhibition Assay | IC50=2.69633 μM | SANGER | |||
| VMRC-RCZ | Growth Inhibition Assay | IC50=2.77328 μM | SANGER | |||
| SK-UT-1 | Growth Inhibition Assay | IC50=3.1531 μM | SANGER | |||
| SW962 | Growth Inhibition Assay | IC50=3.20352 μM | SANGER | |||
| DBTRG-05MG | Growth Inhibition Assay | IC50=3.28085 μM | SANGER | |||
| PANC-08-13 | Growth Inhibition Assay | IC50=3.41278 μM | SANGER | |||
| QIMR-WIL | Growth Inhibition Assay | IC50=3.41341 μM | SANGER | |||
| SK-MEL-30 | Growth Inhibition Assay | IC50=3.42598 μM | SANGER | |||
| 697 | Growth Inhibition Assay | IC50=3.44993 μM | SANGER | |||
| NY | Growth Inhibition Assay | IC50=3.45022 μM | SANGER | |||
| ES7 | Growth Inhibition Assay | IC50=3.46729 μM | SANGER | |||
| JVM-3 | Growth Inhibition Assay | IC50=3.48077 μM | SANGER | |||
| U031 | Growth Inhibition Assay | IC50=3.59368 μM | SANGER | |||
| BHT-101 | Growth Inhibition Assay | IC50=3.59985 μM | SANGER | |||
| 8305C | Growth Inhibition Assay | IC50=3.61736 μM | SANGER | |||
| MG-63 | Growth Inhibition Assay | IC50=3.62676 μM | SANGER | |||
| NOS-1 | Growth Inhibition Assay | IC50=3.65312 μM | SANGER | |||
| YH-13 | Growth Inhibition Assay | IC50=3.87189 μM | SANGER | |||
| LXF-289 | Growth Inhibition Assay | IC50=3.91041 μM | SANGER | |||
| GOTO | Growth Inhibition Assay | IC50=3.9149 μM | SANGER | |||
| EKVX | Growth Inhibition Assay | IC50=4.22524 μM | SANGER | |||
| CAL-51 | Growth Inhibition Assay | IC50=4.24854 μM | SANGER | |||
| AN3-CA | Growth Inhibition Assay | IC50=4.25813 μM | SANGER | |||
| IA-LM | Growth Inhibition Assay | IC50=4.27935 μM | SANGER | |||
| KU-19-19 | Growth Inhibition Assay | IC50=4.32921 μM | SANGER | |||
| A704 | Growth Inhibition Assay | IC50=4.40888 μM | SANGER | |||
| RH-18 | Growth Inhibition Assay | IC50=4.44953 μM | SANGER | |||
| IST-MEL1 | Growth Inhibition Assay | IC50=4.58263 μM | SANGER | |||
| LU-134-A | Growth Inhibition Assay | IC50=4.59685 μM | SANGER | |||
| SF126 | Growth Inhibition Assay | IC50=4.60715 μM | SANGER | |||
| EFO-27 | Growth Inhibition Assay | IC50=4.66525 μM | SANGER | |||
| SN12C | Growth Inhibition Assay | IC50=4.71898 μM | SANGER | |||
| L-363 | Growth Inhibition Assay | IC50=4.77116 μM | SANGER | |||
| MEL-HO | Growth Inhibition Assay | IC50=4.77989 μM | SANGER | |||
| TYK-nu | Growth Inhibition Assay | IC50=4.80128 μM | SANGER | |||
| MDA-MB-415 | Growth Inhibition Assay | IC50=5.00314 μM | SANGER | |||
| HCC70 | Growth Inhibition Assay | IC50=5.03939 μM | SANGER | |||
| IGROV-1 | Growth Inhibition Assay | IC50=5.25292 μM | SANGER | |||
| NCI-H1355 | Growth Inhibition Assay | IC50=5.296 μM | SANGER | |||
| 23132-87 | Growth Inhibition Assay | IC50=5.32024 μM | SANGER | |||
| NB69 | Growth Inhibition Assay | IC50=5.3242 μM | SANGER | |||
| HSC-2 | Growth Inhibition Assay | IC50=5.41773 μM | SANGER | |||
| KYSE-410 | Growth Inhibition Assay | IC50=5.47636 μM | SANGER | |||
| GCIY | Growth Inhibition Assay | IC50=5.51378 μM | SANGER | |||
| A427 | Growth Inhibition Assay | IC50=5.53661 μM | SANGER | |||
| ChaGo-K-1 | Growth Inhibition Assay | IC50=5.56599 μM | SANGER | |||
| PFSK-1 | Growth Inhibition Assay | IC50=5.62194 μM | SANGER | |||
| MLMA | Growth Inhibition Assay | IC50=5.83606 μM | SANGER | |||
| RVH-421 | Growth Inhibition Assay | IC50=6.07338 μM | SANGER | |||
| LB1047-RCC | Growth Inhibition Assay | IC50=6.17522 μM | SANGER | |||
| MHH-NB-11 | Growth Inhibition Assay | IC50=6.32721 μM | SANGER | |||
| J-RT3-T3-5 | Growth Inhibition Assay | IC50=6.63291 μM | SANGER | |||
| UM-UC-3 | Growth Inhibition Assay | IC50=6.64334 μM | SANGER | |||
| IST-SL1 | Growth Inhibition Assay | IC50=6.69369 μM | SANGER | |||
| NB14 | Growth Inhibition Assay | IC50=6.79761 μM | SANGER | |||
| NBsusSR | Growth Inhibition Assay | IC50=6.82502 μM | SANGER | |||
| D-263MG | Growth Inhibition Assay | IC50=6.91068 μM | SANGER | |||
| NCI-H2347 | Growth Inhibition Assay | IC50=6.93213 μM | SANGER | |||
| ES8 | Growth Inhibition Assay | IC50=6.97588 μM | SANGER | |||
| 786-0 | Growth Inhibition Assay | IC50=7.09786 μM | SANGER | |||
| EPLC-272H | Growth Inhibition Assay | IC50=7.16246 μM | SANGER | |||
| CAPAN-1 | Growth Inhibition Assay | IC50=7.24359 μM | SANGER | |||
| NCI-H82 | Growth Inhibition Assay | IC50=7.26659 μM | SANGER | |||
| G-402 | Growth Inhibition Assay | IC50=7.30051 μM | SANGER | |||
| SW982 | Growth Inhibition Assay | IC50=7.30203 μM | SANGER | |||
| OVCAR-4 | Growth Inhibition Assay | IC50=7.31328 μM | SANGER | |||
| KARPAS-299 | Growth Inhibition Assay | IC50=7.32622 μM | SANGER | |||
| MIA-PaCa-2 | Growth Inhibition Assay | IC50=7.36823 μM | SANGER | |||
| AU565 | Growth Inhibition Assay | IC50=7.59833 μM | SANGER | |||
| GAMG | Growth Inhibition Assay | IC50=7.64131 μM | SANGER | |||
| HuO9 | Growth Inhibition Assay | IC50=7.71743 μM | SANGER | |||
| ACN | Growth Inhibition Assay | IC50=7.7433 μM | SANGER | |||
| RO82-W-1 | Growth Inhibition Assay | IC50=7.74533 μM | SANGER | |||
| NKM-1 | Growth Inhibition Assay | IC50=7.74955 μM | SANGER | |||
| CAL-12T | Growth Inhibition Assay | IC50=7.94352 μM | SANGER | |||
| FADU | Growth Inhibition Assay | IC50=8.03654 μM | SANGER | |||
| NCI-H28 | Growth Inhibition Assay | IC50=8.16962 μM | SANGER | |||
| LCLC-97TM1 | Growth Inhibition Assay | IC50=8.21122 μM | SANGER | |||
| CHP-134 | Growth Inhibition Assay | IC50=8.24185 μM | SANGER | |||
| HT-1080 | Growth Inhibition Assay | IC50=8.25093 μM | SANGER | |||
| PC-3 | Growth Inhibition Assay | IC50=8.27392 μM | SANGER | |||
| SNU-449 | Growth Inhibition Assay | IC50=8.2793 μM | SANGER | |||
| VA-ES-BJ | Growth Inhibition Assay | IC50=8.34686 μM | SANGER | |||
| HT | Growth Inhibition Assay | IC50=8.3649 μM | SANGER | |||
| HOS | Growth Inhibition Assay | IC50=8.37589 μM | SANGER | |||
| KNS-62 | Growth Inhibition Assay | IC50=8.37762 μM | SANGER | |||
| OAW-42 | Growth Inhibition Assay | IC50=8.95964 μM | SANGER | |||
| A549 | Growth Inhibition Assay | IC50=9.09612 μM | SANGER | |||
| CAKI-1 | Growth Inhibition Assay | IC50=9.1661 μM | SANGER | |||
| HCC1937 | Growth Inhibition Assay | IC50=9.69865 μM | SANGER | |||
| GI-ME-N | Growth Inhibition Assay | IC50=9.70137 μM | SANGER | |||
| DU-4475 | Growth Inhibition Assay | IC50=9.96939 μM | SANGER | |||
| EM-2 | Growth Inhibition Assay | IC50=10.2426 μM | SANGER | |||
| NCI-H1755 | Growth Inhibition Assay | IC50=10.2428 μM | SANGER | |||
| NCI-H1437 | Growth Inhibition Assay | IC50=10.5725 μM | SANGER | |||
| VM-CUB-1 | Growth Inhibition Assay | IC50=10.6164 μM | SANGER | |||
| A2058 | Growth Inhibition Assay | IC50=10.6404 μM | SANGER | |||
| BPH-1 | Growth Inhibition Assay | IC50=10.7145 μM | SANGER | |||
| NB5 | Growth Inhibition Assay | IC50=10.7559 μM | SANGER | |||
| G-401 | Growth Inhibition Assay | IC50=10.7626 μM | SANGER | |||
| CAL-72 | Growth Inhibition Assay | IC50=10.8094 μM | SANGER | |||
| SK-MEL-28 | Growth Inhibition Assay | IC50=10.8202 μM | SANGER | |||
| C32 | Growth Inhibition Assay | IC50=10.8347 μM | SANGER | |||
| NCI-H1155 | Growth Inhibition Assay | IC50=10.8376 μM | SANGER | |||
| BB49-HNC | Growth Inhibition Assay | IC50=10.8586 μM | SANGER | |||
| GMS-10 | Growth Inhibition Assay | IC50=10.8971 μM | SANGER | |||
| K5 | Growth Inhibition Assay | IC50=10.9071 μM | SANGER | |||
| OS-RC-2 | Growth Inhibition Assay | IC50=11.0559 μM | SANGER | |||
| HTC-C3 | Growth Inhibition Assay | IC50=11.0714 μM | SANGER | |||
| LB996-RCC | Growth Inhibition Assay | IC50=11.0723 μM | SANGER | |||
| NCI-H1563 | Growth Inhibition Assay | IC50=11.1011 μM | SANGER | |||
| CAL-54 | Growth Inhibition Assay | IC50=11.4811 μM | SANGER | |||
| WM-115 | Growth Inhibition Assay | IC50=11.6824 μM | SANGER | |||
| COLO-684 | Growth Inhibition Assay | IC50=11.7267 μM | SANGER | |||
| HOP-62 | Growth Inhibition Assay | IC50=11.7508 μM | SANGER | |||
| NCI-H650 | Growth Inhibition Assay | IC50=11.8961 μM | SANGER | |||
| TE-11 | Growth Inhibition Assay | IC50=11.9315 μM | SANGER | |||
| COLO-679 | Growth Inhibition Assay | IC50=11.946 μM | SANGER | |||
| FTC-133 | Growth Inhibition Assay | IC50=12.0076 μM | SANGER | |||
| D-283MED | Growth Inhibition Assay | IC50=12.0569 μM | SANGER | |||
| SK-PN-DW | Growth Inhibition Assay | IC50=12.1902 μM | SANGER | |||
| BALL-1 | Growth Inhibition Assay | IC50=12.2662 μM | SANGER | |||
| GT3TKB | Growth Inhibition Assay | IC50=12.3074 μM | SANGER | |||
| HOP-92 | Growth Inhibition Assay | IC50=12.5233 μM | SANGER | |||
| M14 | Growth Inhibition Assay | IC50=13.0335 μM | SANGER | |||
| SKG-IIIa | Growth Inhibition Assay | IC50=13.0554 μM | SANGER | |||
| Becker | Growth Inhibition Assay | IC50=13.058 μM | SANGER | |||
| ES5 | Growth Inhibition Assay | IC50=13.1356 μM | SANGER | |||
| NCI-H2030 | Growth Inhibition Assay | IC50=13.2062 μM | SANGER | |||
| SNU-423 | Growth Inhibition Assay | IC50=13.381 μM | SANGER | |||
| CP50-MEL-B | Growth Inhibition Assay | IC50=13.6232 μM | SANGER | |||
| NCI-H1092 | Growth Inhibition Assay | IC50=13.7475 μM | SANGER | |||
| 8-MG-BA | Growth Inhibition Assay | IC50=13.7513 μM | SANGER | |||
| CAL-27 | Growth Inhibition Assay | IC50=14.0727 μM | SANGER | |||
| AGS | Growth Inhibition Assay | IC50=14.1319 μM | SANGER | |||
| MZ2-MEL | Growth Inhibition Assay | IC50=14.1488 μM | SANGER | |||
| BFTC-909 | Growth Inhibition Assay | IC50=14.5055 μM | SANGER | |||
| D-566MG | Growth Inhibition Assay | IC50=14.7706 μM | SANGER | |||
| MZ7-mel | Growth Inhibition Assay | IC50=15.1067 μM | SANGER | |||
| TE-5 | Growth Inhibition Assay | IC50=15.2333 μM | SANGER | |||
| 647-V | Growth Inhibition Assay | IC50=15.2705 μM | SANGER | |||
| DMS-114 | Growth Inhibition Assay | IC50=15.3291 μM | SANGER | |||
| ME-180 | Growth Inhibition Assay | IC50=15.4783 μM | SANGER | |||
| MS-1 | Growth Inhibition Assay | IC50=15.5623 μM | SANGER | |||
| NUGC-3 | Growth Inhibition Assay | IC50=15.6245 μM | SANGER | |||
| GB-1 | Growth Inhibition Assay | IC50=15.6437 μM | SANGER | |||
| LOXIMVI | Growth Inhibition Assay | IC50=15.8919 μM | SANGER | |||
| NCI-H1304 | Growth Inhibition Assay | IC50=15.8928 μM | SANGER | |||
| KURAMOCHI | Growth Inhibition Assay | IC50=15.971 μM | SANGER | |||
| SW1783 | Growth Inhibition Assay | IC50=16.0993 μM | SANGER | |||
| EGI-1 | Growth Inhibition Assay | IC50=16.5365 μM | SANGER | |||
| KGN | Growth Inhibition Assay | IC50=16.5586 μM | SANGER | |||
| PANC-03-27 | Growth Inhibition Assay | IC50=16.7662 μM | SANGER | |||
| RH-1 | Growth Inhibition Assay | IC50=16.825 μM | SANGER | |||
| HT-1376 | Growth Inhibition Assay | IC50=16.8446 μM | SANGER | |||
| ZR-75-30 | Growth Inhibition Assay | IC50=16.9361 μM | SANGER | |||
| TI-73 | Growth Inhibition Assay | IC50=16.9408 μM | SANGER | |||
| TK10 | Growth Inhibition Assay | IC50=17.0079 μM | SANGER | |||
| SW684 | Growth Inhibition Assay | IC50=17.0154 μM | SANGER | |||
| RPMI-8866 | Growth Inhibition Assay | IC50=17.0699 μM | SANGER | |||
| LNCaP-Clone-FGC | Growth Inhibition Assay | IC50=17.5201 μM | SANGER | |||
| NCI-H2291 | Growth Inhibition Assay | IC50=18.4345 μM | SANGER | |||
| T47D | Growth Inhibition Assay | IC50=18.488 μM | SANGER | |||
| A204 | Growth Inhibition Assay | IC50=18.5452 μM | SANGER | |||
| HT-144 | Growth Inhibition Assay | IC50=18.7427 μM | SANGER | |||
| MDA-MB-361 | Growth Inhibition Assay | IC50=19.0714 μM | SANGER | |||
| HCC1806 | Growth Inhibition Assay | IC50=19.1591 μM | SANGER | |||
| NCI-H596 | Growth Inhibition Assay | IC50=19.6391 μM | SANGER | |||
| K-562 | Growth Inhibition Assay | IC50=19.8926 μM | SANGER | |||
| D-336MG | Growth Inhibition Assay | IC50=19.9322 μM | SANGER | |||
| SK-MEL-2 | Growth Inhibition Assay | IC50=20.1559 μM | SANGER | |||
| HEC-1 | Growth Inhibition Assay | IC50=20.4978 μM | SANGER | |||
| EW-13 | Growth Inhibition Assay | IC50=20.5443 μM | SANGER | |||
| Hs-578-T | Growth Inhibition Assay | IC50=20.5583 μM | SANGER | |||
| SJSA-1 | Growth Inhibition Assay | IC50=20.5688 μM | SANGER | |||
| RCC10RGB | Growth Inhibition Assay | IC50=20.6719 μM | SANGER | |||
| LAN-6 | Growth Inhibition Assay | IC50=21.0396 μM | SANGER | |||
| NCI-H1048 | Growth Inhibition Assay | IC50=21.2258 μM | SANGER | |||
| CW-2 | Growth Inhibition Assay | IC50=21.2705 μM | SANGER | |||
| HCC2157 | Growth Inhibition Assay | IC50=21.36 μM | SANGER | |||
| EW-22 | Growth Inhibition Assay | IC50=21.376 μM | SANGER | |||
| A253 | Growth Inhibition Assay | IC50=21.4481 μM | SANGER | |||
| BE-13 | Growth Inhibition Assay | IC50=21.6113 μM | SANGER | |||
| KINGS-1 | Growth Inhibition Assay | IC50=21.6316 μM | SANGER | |||
| ETK-1 | Growth Inhibition Assay | IC50=21.8152 μM | SANGER | |||
| NCI-H2452 | Growth Inhibition Assay | IC50=21.8647 μM | SANGER | |||
| HPAF-II | Growth Inhibition Assay | IC50=21.8923 μM | SANGER | |||
| D-542MG | Growth Inhibition Assay | IC50=21.9069 μM | SANGER | |||
| NCI-H630 | Growth Inhibition Assay | IC50=22.0296 μM | SANGER | |||
| TGBC11TKB | Growth Inhibition Assay | IC50=22.049 μM | SANGER | |||
| BCPAP | Growth Inhibition Assay | IC50=22.611 μM | SANGER | |||
| HLE | Growth Inhibition Assay | IC50=22.697 μM | SANGER | |||
| NCI-H727 | Growth Inhibition Assay | IC50=22.735 μM | SANGER | |||
| RD | Growth Inhibition Assay | IC50=22.7518 μM | SANGER | |||
| NCI-H522 | Growth Inhibition Assay | IC50=22.8431 μM | SANGER | |||
| CGTH-W-1 | Growth Inhibition Assay | IC50=23.0641 μM | SANGER | |||
| SK-LU-1 | Growth Inhibition Assay | IC50=23.4683 μM | SANGER | |||
| BB65-RCC | Growth Inhibition Assay | IC50=23.7863 μM | SANGER | |||
| HSC-3 | Growth Inhibition Assay | IC50=23.8527 μM | SANGER | |||
| SK-MES-1 | Growth Inhibition Assay | IC50=24.0161 μM | SANGER | |||
| DB | Growth Inhibition Assay | IC50=24.1028 μM | SANGER | |||
| HO-1-N-1 | Growth Inhibition Assay | IC50=24.3093 μM | SANGER | |||
| MKN1 | Growth Inhibition Assay | IC50=24.68 μM | SANGER | |||
| MN-60 | Growth Inhibition Assay | IC50=24.8519 μM | SANGER | |||
| 8505C | Growth Inhibition Assay | IC50=25.1845 μM | SANGER | |||
| COLO-320-HSR | Growth Inhibition Assay | IC50=25.2208 μM | SANGER | |||
| BB30-HNC | Growth Inhibition Assay | IC50=25.2483 μM | SANGER | |||
| KM12 | Growth Inhibition Assay | IC50=25.5807 μM | SANGER | |||
| NB13 | Growth Inhibition Assay | IC50=25.5898 μM | SANGER | |||
| HCC2998 | Growth Inhibition Assay | IC50=26.0283 μM | SANGER | |||
| U-118-MG | Growth Inhibition Assay | IC50=26.0808 μM | SANGER | |||
| NB10 | Growth Inhibition Assay | IC50=26.234 μM | SANGER | |||
| SK-LMS-1 | Growth Inhibition Assay | IC50=27.0704 μM | SANGER | |||
| SW1573 | Growth Inhibition Assay | IC50=27.11 μM | SANGER | |||
| LB373-MEL-D | Growth Inhibition Assay | IC50=27.1294 μM | SANGER | |||
| DK-MG | Growth Inhibition Assay | IC50=27.1817 μM | SANGER | |||
| RMG-I | Growth Inhibition Assay | IC50=27.2029 μM | SANGER | |||
| SW1088 | Growth Inhibition Assay | IC50=27.5042 μM | SANGER | |||
| SK-OV-3 | Growth Inhibition Assay | IC50=27.7593 μM | SANGER | |||
| KP-N-YN | Growth Inhibition Assay | IC50=27.8043 μM | SANGER | |||
| RPMI-7951 | Growth Inhibition Assay | IC50=28.2456 μM | SANGER | |||
| CaR-1 | Growth Inhibition Assay | IC50=28.5582 μM | SANGER | |||
| MKN7 | Growth Inhibition Assay | IC50=28.5964 μM | SANGER | |||
| CHP-212 | Growth Inhibition Assay | IC50=28.7401 μM | SANGER | |||
| KYSE-450 | Growth Inhibition Assay | IC50=28.8091 μM | SANGER | |||
| RXF393 | Growth Inhibition Assay | IC50=29.2906 μM | SANGER | |||
| P30-OHK | Growth Inhibition Assay | IC50=29.3048 μM | SANGER | |||
| Ca9-22 | Growth Inhibition Assay | IC50=29.4299 μM | SANGER | |||
| RT-112 | Growth Inhibition Assay | IC50=29.4611 μM | SANGER | |||
| ES1 | Growth Inhibition Assay | IC50=29.8544 μM | SANGER | |||
| HCE-4 | Growth Inhibition Assay | IC50=29.8786 μM | SANGER | |||
| AM-38 | Growth Inhibition Assay | IC50=30.0606 μM | SANGER | |||
| AsPC-1 | Growth Inhibition Assay | IC50=30.8053 μM | SANGER | |||
| TE-9 | Growth Inhibition Assay | IC50=30.8737 μM | SANGER | |||
| HuP-T4 | Growth Inhibition Assay | IC50=30.9638 μM | SANGER | |||
| LB2518-MEL | Growth Inhibition Assay | IC50=31.0744 μM | SANGER | |||
| NCI-H1703 | Growth Inhibition Assay | IC50=31.0905 μM | SANGER | |||
| NCI-H2228 | Growth Inhibition Assay | IC50=31.4651 μM | SANGER | |||
| SCC-4 | Growth Inhibition Assay | IC50=31.9181 μM | SANGER | |||
| KNS-81-FD | Growth Inhibition Assay | IC50=32.0128 μM | SANGER | |||
| NTERA-S-cl-D1 | Growth Inhibition Assay | IC50=32.0739 μM | SANGER | |||
| Daoy | Growth Inhibition Assay | IC50=32.0838 μM | SANGER | |||
| ES4 | Growth Inhibition Assay | IC50=32.3922 μM | SANGER | |||
| MHH-ES-1 | Growth Inhibition Assay | IC50=32.4872 μM | SANGER | |||
| C-33-A | Growth Inhibition Assay | IC50=32.7728 μM | SANGER | |||
| BHY | Growth Inhibition Assay | IC50=32.9495 μM | SANGER | |||
| Detroit562 | Growth Inhibition Assay | IC50=33.6657 μM | SANGER | |||
| EW-1 | Growth Inhibition Assay | IC50=33.9322 μM | SANGER | |||
| NCI-H1395 | Growth Inhibition Assay | IC50=34.0799 μM | SANGER | |||
| KM-H2 | Growth Inhibition Assay | IC50=36.4743 μM | SANGER | |||
| NCI-H520 | Growth Inhibition Assay | IC50=36.7541 μM | SANGER | |||
| D-392MG | Growth Inhibition Assay | IC50=37.3344 μM | SANGER | |||
| NOMO-1 | Growth Inhibition Assay | IC50=37.8089 μM | SANGER | |||
| TE-6 | Growth Inhibition Assay | IC50=38.124 μM | SANGER | |||
| HT-3 | Growth Inhibition Assay | IC50=38.4436 μM | SANGER | |||
| RPMI-8226 | Growth Inhibition Assay | IC50=38.9519 μM | SANGER | |||
| U251 | Growth Inhibition Assay | IC50=39.0124 μM | SANGER | |||
| GCT | Growth Inhibition Assay | IC50=39.1852 μM | SANGER | |||
| A431 | Growth Inhibition Assay | IC50=39.1894 μM | SANGER | |||
| TE-12 | Growth Inhibition Assay | IC50=39.2448 μM | SANGER | |||
| HMV-II | Growth Inhibition Assay | IC50=39.5047 μM | SANGER | |||
| IST-MES1 | Growth Inhibition Assay | IC50=40.1502 μM | SANGER | |||
| SW13 | Growth Inhibition Assay | IC50=40.519 μM | SANGER | |||
| SF295 | Growth Inhibition Assay | IC50=40.8066 μM | SANGER | |||
| MDA-MB-157 | Growth Inhibition Assay | IC50=40.9462 μM | SANGER | |||
| TE-1 | Growth Inhibition Assay | IC50=41.8714 μM | SANGER | |||
| HuCCT1 | Growth Inhibition Assay | IC50=42.5289 μM | SANGER | |||
| KYSE-510 | Growth Inhibition Assay | IC50=43.1754 μM | SANGER | |||
| NCI-H358 | Growth Inhibition Assay | IC50=44.0304 μM | SANGER | |||
| SW900 | Growth Inhibition Assay | IC50=44.0758 μM | SANGER | |||
| CAS-1 | Growth Inhibition Assay | IC50=44.0991 μM | SANGER | |||
| TE-8 | Growth Inhibition Assay | IC50=44.5658 μM | SANGER | |||
| P12-ICHIKAWA | Growth Inhibition Assay | IC50=44.6112 μM | SANGER | |||
| YKG-1 | Growth Inhibition Assay | IC50=44.781 μM | SANGER | |||
| SNU-C2B | Growth Inhibition Assay | IC50=44.7903 μM | SANGER | |||
| LCLC-103H | Growth Inhibition Assay | IC50=44.8703 μM | SANGER | |||
| U-87-MG | Growth Inhibition Assay | IC50=45.1022 μM | SANGER | |||
| HAL-01 | Growth Inhibition Assay | IC50=45.1379 μM | SANGER | |||
| OVCAR-8 | Growth Inhibition Assay | IC50=45.3564 μM | SANGER | |||
| KYSE-150 | Growth Inhibition Assay | IC50=47.1052 μM | SANGER | |||
| OE33 | Growth Inhibition Assay | IC50=47.1429 μM | SANGER | |||
| CAL-62 | Growth Inhibition Assay | IC50=47.4068 μM | SANGER | |||
| TCCSUP | Growth Inhibition Assay | IC50=47.6264 μM | SANGER | |||
| H4 | Growth Inhibition Assay | IC50=47.6621 μM | SANGER | |||
| CP66-MEL | Growth Inhibition Assay | IC50=48.0704 μM | SANGER | |||
| SNB75 | Growth Inhibition Assay | IC50=48.1874 μM | SANGER | |||
| Mo-T | Growth Inhibition Assay | IC50=48.279 μM | SANGER | |||
| BT-549 | Growth Inhibition Assay | IC50=48.3729 μM | SANGER | |||
| IGR-1 | Growth Inhibition Assay | IC50=48.6645 μM | SANGER | |||
| NCI-H1299 | Growth Inhibition Assay | IC50=48.7248 μM | SANGER | |||
| ALL-PO | Growth Inhibition Assay | IC50=49.9268 μM | SANGER | |||
| CLL | Function assay | Inhibition of DNA-PK autophosphorylation at Ser2056 residue in human CLL cells by Western blot method, IC50 = 0.03 μM. | 22835870 | |||
| HeLa | Function assay | Inhibition of DNA-PK autophosphorylation at S2056 in human HeLa cells, EC50 = 0.212 μM. | 23855836 | |||
| CHO | Function assay | Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay, IC50 = 14 μM. | 23855836 | |||
| A673 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 29435139 | |||
| DAOY | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 29435139 | |||
| Saos-2 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 29435139 | |||
| BT-37 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 29435139 | |||
| RD | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells | 29435139 | |||
| BT-12 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 29435139 | |||
| MG 63 (6-TG R) | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells | 29435139 | |||
| NB1643 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 29435139 | |||
| OHS-50 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 29435139 | |||
| SJ-GBM2 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 29435139 | |||
| SK-N-MC | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 29435139 | |||
| NB-EBc1 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 29435139 | |||
| LAN-5 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 29435139 | |||
| Rh18 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells | 29435139 | |||
| INA-6 | Function assay | 10 uM | 4 hrs | Inhibition of heat shock response in human INA-6 cells assessed as reduction in HSF-1 mediated upregulation of the HSP72 protein expression at 10 uM preincubated for 4 hrs followed by HSP90 inhibitor and HSR inducer NVP-AUY922 addition measured after 4 hr | 28453931 | |
| INA-6 | Function assay | 10 uM | 4 hrs | Inhibition of heat shock response in human INA-6 cells assessed as reduction in HSF-1 mediated upregulation of the HSP72 mRNA expression at 10 uM preincubated for 4 hrs followed by HSP90 inhibitor and HSR inducer NVP-AUY922 addition measured after 4 hrs b | 28453931 | |
| INA-6 | Function assay | 10 uM | 4 hrs | Downregulation of NVP-AUY922-induced HSF-1 protein expression in human INA-6 cells at 10 uM preincubated for 4 hrs followed by NVP-AUY922 addition measured after 4 hrs by Western blot method | 28453931 | |
| INA-6 | Function assay | 10 uM | 4 hrs | Inhibition of NVP-AUY922-induced HSF-1 phosphorylation in human INA-6 cells at 10 uM preincubated for 4 hrs followed by NVP-AUY922 addition measured after 4 hrs by Western blot method | 28453931 | |
| INA-6 | Function assay | 10 uM | 4 hrs | Downregulation of NVP-AUY922-induced HSF-1 mRNA expression in human INA-6 cells at 10 uM preincubated for 4 hrs followed by NVP-AUY922 addition measured after 4 hrs by RT-PCR method | 28453931 | |
| 클릭하여 더 많은 세포주 실험 데이터 보기 | ||||||
| 분자량 | 413.49 | 화학식 | C25H19NO3S |
보관 (수령일로부터) | |
|---|---|---|---|---|---|
| CAS 번호 | 503468-95-9 | SDF 다운로드 | 원액 보관 |
|
|
| 동의어 | N/A | Smiles | C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56 | ||
|
In vitro |
DMSO
: 5 mg/mL
(12.09 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
1단계: 아래 정보 입력 (권장: 실험 중 손실을 고려하여 추가 동물 포함)
2단계: 생체 내 제형 입력 (이것은 계산기일 뿐 제형이 아닙니다. 용해도 섹션에 생체 내 제형이 없는 경우 먼저 당사에 문의하십시오.)
계산 결과:
작업 농도: mg/ml;
DMSO 원액 준비 방법: mg 약물 사전 용해 μL DMSO ( 원액 농도 mg/mL, 농도가 해당 약물 배치의 DMSO 용해도를 초과하는 경우 먼저 당사에 문의하십시오. )
생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가μL PEG300, 혼합하고 투명하게 한 다음 추가μL Tween 80, 혼합하고 투명하게 한 다음 추가 μL ddH2O, 혼합하고 투명하게 합니다.
생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가 μL 옥수수 기름, 혼합하고 투명하게 합니다.
참고: 1. 다음 용매를 추가하기 전에 액체가 투명한지 확인하십시오.
2. 용매를 순서대로 추가해야 합니다. 다음 용매를 추가하기 전에 이전 추가에서 얻은 용액이 투명한 용액인지 확인해야 합니다. 와동, 초음파 또는 뜨거운 물 중탕과 같은 물리적 방법을 사용하여 용해를 도울 수 있습니다.
| Targets/IC50/Ki |
DNA-PK
(Cell-free assay) 14 nM
mTOR
(cell-free assay) 1.7 μM
PI3K
(cell-free assay) 5 μM
|
|---|---|
| 시험관 내(In vitro) |
NU7441 (KU-57788)은 전리 방사선 유발 DNA 손상 후 γH2AX foci의 지속성을 증가시킵니다. 이는 (0.5 μM 또는 1 μM) SW620 및 LoVo 세포 모두에서 전리 방사선 및 독소루비신에 의해 유도된 G2-M 축적을 현저히 증가시킵니다. 이 화합물은 독소루비신 및 전리 방사선 유발 DNA 이중 가닥 손상의 지속성을 유발하며, DNA-PK-능숙한 M059-Fus-1 및 DNA-PK-결핍 M059 J 인간 종양 세포에서 상동 재조합 활동을 약간 감소시킵니다. 이는 폴리머라제 η가 없는 세포와 폴리머라제 η를 발현하는 세포 모두에서 UV 유발 RPA p34 과인산화를 용량 의존적으로 억제합니다. NU7441은 -유발 γH2AX foci 수준을 증가시키고 만성 림프구성 백혈병 세포에서 -유발 세포 사멸을 correspondingly 감소시킵니다. 또한 만성 림프구성 백혈병 세포에서 -유발 DNA-PKcs 자가인산화 및 복구를 억제합니다. 이 화합물은 Cas9 매개 DNA 절단 후 NHEJ 빈도를 줄이는 동시에 HDR 속도를 증가시킵니다. |
| 생체 내(In vivo) |
NU7441 (KU-57788)을 10 mg/kg 용량으로 복강 내 투여하면 최소 4시간 동안 유지되며 독성이 없고 SW620 이종이식편을 가진 마우스에서 유도된 종양 성장 지연을 2배 증가시킵니다. |
참조 |
|
| 방법 | 바이오마커 | 이미지 | PMID |
|---|---|---|---|
| Western blot | p-DNA-PKcs / DNA-PKcs / p-ATM / ATM / p-ATR / ATR / Ku70 / p-CHK1 / p-CHK2/ p-AKT / RAD51 p-mTOR(Ser2448) / mTOR / p-S6K(Thr389) |
|
29344644 |
질문 1:
Could you please suggest formulations of it for in vivo injection?
답변:
We tested the following formulation for in vivo use: 4% DMSO+30% PEG 300+5% Tween 80+ddH2O up to 1mg/mL. It is a clear solution.
질문 2:
Previous aliquots were clear and colorless while this time, it becomes yellow when the powder was dissolved in DMSO? Could you advice on this?
답변:
It is normal and usually doesn't interfere with the function due to slight color variation caused by different processing.